Interferon‐Inducible ADAR1 p150 Is Essential for the Survival of Oral Squamous Cell Carcinoma
Molecular Carcinogenesis · 2025-06 · 64 (6) · 1066-1077
DOI: 10.1002/mc.23910 ↗At a glance
Journal article in Molecular Carcinogenesis, published online on 2025-03-26. Written by Pei San Yee and 7 co-authors. Institution: Translational Cancer Biology Research Unit, Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia. Major MEDLINE topics: Adenosine Deaminase, RNA-Binding Proteins, Mouth Neoplasms, Carcinoma, Squamous Cell. Cited 4 times so far (Crossref); 40 references. Funded by: This study was funded by the Dr. Siti Hasmah Mohd Ali Professorial Chair appointment (PV061-2019) and Fundamental Research Grant Scheme (FRGS/1/2022/SKK10/USM/….
Abstract (original language)
We identified ADAR1 as one of the top essential genes for oral squamous cell carcinoma (OSCC) survival from our genome‐wide CRISPR/Cas9 screen in OSCC cell lines. In this study, we confirm that ADAR1‐knockout (KO) inhibits cell viability and colony forming ability, and induces apoptosis. We report that IFN‐β treatment sensitizes less‐dependent cell lines to ADAR1 KO‐induced cell lethality. Overexpression of ADAR1‐p150, but not ADAR1‐p110, rescued cell lethality upon ADAR1 KO, confirming that the IFN‐inducible p150 is responsible for OSCC survival. Using a deaminase inactive mutant, we demonstrate that the editing function of ADAR1 is important for OSCC survival. Furthermore, we show that ADAR1 KO‐induced cell death is mediated by both PKR and MDA5. We compute gene signatures of ADAR1 dependency in OSCC tumors, and found that those with high ADAR1 dependency score are associated with well or moderate differentiation, likely due to high PKR expression or activation. While a majority of ADAR1‐dependent tumors exhibit a low T cell–inflamed gene expression profile, ADAR1 KO upregulates PD‐L1, a marker of anti‐PD1 response, indicating that ADAR1 inhibition may enhance immunotherapy response in OSCC. Collectively, these findings suggest that targeting ADAR1‐p150 not only induces OSCC cell death but could induce a favorable response to anti‐PD1.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Translational Cancer Biology Research Unit, Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
- Department of Oral & Maxillofacial Clinical Sciences, Faculty of Dentistry, University of Malaya, Kuala Lumpur, Malaysia.
- Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
- Advanced Medical and Dental Institute, Universiti Sains Malaysia, Bertam, Kepala Batas, Pulau Pinang, Malaysia.
Funding
- This study was funded by the Dr. Siti Hasmah Mohd Ali Professorial Chair appointment (PV061-2019) and Fundamental Research Grant Scheme (FRGS/1/2022/SKK10/USM/…
Cite
APA
Yee, P. S., Chai, A. W. Y., Yee, S. M., Ooi, S., Tan, Y. H., Garnett, M. J., Ng, S. K., & Cheong, S. C. (2025). Interferon‐Inducible ADAR1 p150 Is Essential for the Survival of Oral Squamous Cell Carcinoma. Molecular Carcinogenesis, 64(6), 1066-1077. https://doi.org/10.1002/mc.23910
Vancouver
Yee PS, Chai AWY, Yee SM, Ooi S, Tan YH, Garnett MJ, et al. Interferon‐Inducible ADAR1 p150 Is Essential for the Survival of Oral Squamous Cell Carcinoma. Molecular Carcinogenesis. 2025;64(6):1066-1077. doi:10.1002/mc.23910
BibTeX
@article{Yee2025,
author = {Yee, Pei San and Chai, Annie Wai Yeeng and Yee, Shi Mun and Ooi, Shiyin and Tan, Yee Hua and Garnett, Mathew J and Ng, Siew Kit and Cheong, Sok Ching},
title = {Interferon‐Inducible ADAR1 p150 Is Essential for the Survival of Oral Squamous Cell Carcinoma},
journal = {Molecular Carcinogenesis},
year = {2025},
volume = {64},
number = {6},
pages = {1066--1077},
doi = {10.1002/mc.23910}
}
EUVIMED